SCHEMBL23360736

SCHEMBL23360736

O=C(O)Nc1c([N+](=O)[O-])ccc(N2CCCCC2=O)c1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.44
▸ HTT P42858 3/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ GAA P10253 1/20 0.44
▸ MAPT P10636 5/20 0.41
▸ POLB P06746 4/20 0.39
▸ PKM P14618 1/20 0.39
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ KMT2A Q03164 5/20 0.37
▸ CASP6 P55212 1/20 0.37
▸ MEN1 O00255 4/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28457664 0.84 ALDH1A1 (0.39) ALDH1A1HTTKDM4EGAAMAPT
SCHEMBL23360737 0.82 ALDH1A1 (0.58) ALDH1A1HTTGAAMAPTPOLB
SCHEMBL25796769 0.81 HTT (0.49) ALDH1A1HTTKDM4EGAAMAPT
SCHEMBL30168936 0.79 KDM4E (0.53) ALDH1A1HTTKDM4EGAAMAPT
SCHEMBL21001112 0.79 KDM4E (0.53) ALDH1A1HTTKDM4EGAAMAPT
SCHEMBL23360731 0.76 KDM4E (0.46) ALDH1A1HTTKDM4EGAAMAPT
SCHEMBL21001153 0.75 ALDH1A1 (0.40) ALDH1A1HTTKDM4EGAAMAPT
SCHEMBL29805501 0.72 KDM4E (0.60) ALDH1A1HTTKDM4EGAAMAPT
SCHEMBL23168572 0.72 HSD17B10 (0.42) ALDH1A1HTTKDM4EGAAL3MBTL1
SCHEMBL16189968 0.68 ALDH1A1 (0.60) ALDH1A1HTTKDM4EGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691970-B2 Pyrazolopyridinone compounds JANSSEN PHARMACEUTICA NV (BE) 2023-07-04 — — US disclosed
EP-3713941-B1 PYRAZOLOPYRIDINONE COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2022-06-22 — — EP disclosed
US-20210147411-A1 PYRAZOLOPYRIDINONE COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2021-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210147411-A1 PYRAZOLOPYRIDINONE COMPOUNDS FGFR1, FGFR3, FGFR2 ALDH1A1 1418/4885HTT 1848/4885KDM4E 964/4885
US-11691970-B2 Pyrazolopyridinone compounds FGFR1, FGFR3, FGFR2 ALDH1A1 1418/4885HTT 1848/4885KDM4E 964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback